Session: Prevention and Treatment of Co-Occurring Substance Abuse and Mental Disorders
5142.0: Wednesday, November 19, 2003: 2:30 PM-4:00 PM
Oral
Prevention and Treatment of Co-Occurring Substance Abuse and Mental Disorders
Learning Objectives: Refer to the individual abstracts for learning objectives
See individual abstracts for presenting author's disclosure statement and author's information.
Moderator(s):George Kanuck
2:30 PMSAMHSA's report to congress on the prevention and treatment of co-occurring substance abuse and mental disorders
George Kanuck
2:48 PMAccess to mental health treatment for persons with co-occurring disorders in methadone programs: A comparison of integrated and parallel treatment approaches
Terri S. Tobin, PhD, John A. Hornik, PhD, Blossom Davies, PhD
3:06 PMStrategies to increase the recognition and referral of co-occurring disorders in a primary care setting
Kelly Vander Ley, PhD, Meg Hayes, MD, Chandra Lewis, MS, Jennifer Lembach, BA, Gillian Leichtling, BA, Roy M. Gabriel, PhD
3:24 PMIntervention for co-occurring substance use and trauma disorders: A randomized controlled trial
Hsiu-Ju Lin, MA, Linda Frisman, PhD, Julian Ford, PhD, Sharon Mallon, PhD
3:42 PMSelf-medication and the utilization of mental health services in the national comorbidity survey
George J Unick, MSW, MA, Lonnie Snowden, PhD
Organized by:Alcohol, Tobacco, and Other Drugs
Endorsed by:Public Health Education and Health Promotion
CE Credits:CME, Health Education (CHES), Nursing, Pharmacy

The 131st Annual Meeting (November 15-19, 2003) of APHA